20043 ⎘
Medicinal preparations characterised by special physical form; Galenical forms characterised by the site of application; Pulmonary tract; Aromatherapy; Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy; for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
Prostacyclin compounds, compositions and methods of use thereof
#602Pharmaceutical composition containing a mixture of proenzymes and enzymes
#603METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO ENABLE RAPID RELIEF OF MIGRAINE WHILE MINIMIZING SIDE EFFECT PROFILE
#604Treating inflammation with inhaled aspirin
#605INHALABLE POWDER COMPOSITION COMPRISING IL-13 ANTIBODY
#606Single-dose dual-compartment drug delivery system
#607Peptide YY pharmaceutical formulations, compositions, and methods
#608PHOSPHODIESTERASE INHIBITOR TREATMENT
#609Medicinal composition for inhalation
#610Cromolyn compositions for treatment of pulmonary fibrosis
#611Cromolyn compositions for treatment of pulmonary fibrosis
#612Tobacco products
#613PROCESS FOR PROVIDING PARTICLES WITH REDUCED ELECTROSTATIC CHARGES
#614Particles with RNA cleaving nucleobase polymers and uses for managing inflammatory disorders
#6151-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
#616Quinuclidine derivatives and medicinal compositions containing the same
#617Dry powder inhaler and system for drug delivery
#618Mast cell stabilizers treatment for systemic disorders
#619Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
#620Microparticles comprising a sulphur-containing compound
#621Particle size stabilization process
#622Delivery of Active Agents
#623ITRACONAZOLE DRY POWDERS
#624Dry powder treprostinil for the treatment of pulmonary hypertension
#625NICOTINE PARTICLES AND COMPOSITIONS
#626Nanocrystal Microparticles of Poorly Soluble Drugs and Methods of Production and Use Thereof
#627Inhalable rapamycin formulation for treating age-related conditions
#628MIR-29 MIMICS AND USES THEREOF
#629Powder formulation
#630Nicotine particles
#631Inhalable nicotine formulations, and methods of making and using thereof
#632Methods and compositions for treating aging-associated impairments using CCR3-inhibitors
#633Dry powder formulations and methods of use
#634Inhibitor of p38 MAP kinase
#635Glucocorticoid combined with polyethylene glycol-modified interleukin 2 for treating respiratory disease
#636COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#637Dry powder formulations for inhalation
#638INHALER AND MESH FOR AN INHALER
#639High capacity diketopiperazine microparticles and methods
#640Technology for the Preparation of Microparticles
#641VAPOR MEDICINE DISPENSING AND NANO-MIST LUNG CLEANSER SYSTEM WITH FACE ADAPTER
#642Dry powder formation using a variably constrained, divided pathway for mixing fluid streams
#643Diketopiperazine salts for drug delivery and related methods
#644Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
#645DRY POWDER FOR INHALATION
#646Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
#647Powdered formulations of cromolyn sodium and ibuprofen
#648Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#649Antifungal Agent
#650Use of stearate in an inhalable formulation
#651Propofol formulations with non-reactive container closures
#652Flavored nicotine powder
#653Methods of treating or preventing fibrotic lung diseases
#654Process for the preparation of aclidinium bromide
#655Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#656Biologic scaffold for prevention of pulmonary fibrosis
#657Inhaler Device for Administering Powered Pharmaceutical Compositions via Inhalation
#658Carrier particles for dry powder formulations for inhalation
#659Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
#660METHODS AND COMPOSITIONS FOR TREATING PULMONARY HYPERTENSION
#661Aerosilization of stem cells or stem cell derivatives for pulmonary delivery
#662Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#663Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#664Acute Respiratory Distress Syndrome Therapeutic Agent
#665Inhalable Pharmaceutical Compositions
#666Powder filling processes
#667Methods of treatment using a JAK inhibitor compound
#668Crystalline forms of a JAK inhibitor compound
#669HYDROXYPROPYL METHYL CELLULOSE HARD CAPSULES AND PROCESS OF MANUFACTURE
#670Dry powder inhalation device
#671Use of ultrarapid acting insulin
#672Dosage and formulation
#673TARGETED DELIVERY OF SPRAY-DRIED FORMULATIONS TO THE LUNGS
#674Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
#675BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS
#676Devices and methods for delivering dry powder medicaments
#677Extracellular matrix compositions with bactericidal or bacteriostatic characteristics useful for protecting and treating patients with bacterial infections
#6786-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
#679PALONOSETRON FORMULATIONS AND USES THEREOF
#680Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
#681Methods of treating and/or preventing chronic obstructive pulmonary disease
#682Mast cell stabilizers treatment for systemic disorders
#683Dry powder inhaler
#684COMBINATION OF NITRIC OXIDE, HELIUM AND ANTIBIOTIC TO TREAT BACTERIAL LUNG INFECTIONS
#685Formulation and manufacture of pharmaceuticals by impregnation onto porous carriers
#686Codon-optimized CFTR MRNA
#687Pharmaceutical Combination
#6886-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
#689DRY POWDER PHARMACEUTICAL COMPOSITIONS AND METHODS
#690INHALABLE POWDER FORMULATIONS OF ALGINATE OLIGOMERS
#691Dry powder inhaler and system for drug delivery
#6921-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as p38 MAP kinase inhibitors
#693Antimicrobial and anti-inflammatory compositions
#694Respiratory formulations and compounds for use therein
#695Dry Powder Inhaler Apparatus
#696COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS
#697COMPOSITIONS AND METHODS FOR TREATING LUNG DISEASES AND LUNG INJURY
#698Rapamycin for the treatment of lymphangioleiomyomatosis
#699SPRAY DRY FORMULATIONS
#700CROMOLYN COMPOSITIONS FOR TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS
#701Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
#702Method of treating diabetes type 2 by administering ultrarapid acting insulin
#703Manufacture of pharmaceutical compositions
#704PROCESS FOR THE PREPARATION OF POROUS MICROPARTICLES
#705Methods and products for treating and/or delaying onset of dysplastic lesions
#706DRY POWDER FORMULATIONS AND METHODS FOR TREATING PULMONARY DISEASES
#707Cromolyn compositions and methods thereof
#708MULTIDRUG BRITTLE MATRIX COMPOSITIONS
#709Once-daily treatment of pulmonary fibrosis
#710USE OF MAGNESIUM STEARATE IN DRY POWDER FORMULATIONS FOR INHALATION
#711Pyrazolyl ureas as kinase inhibitors
#712Combination therapy for treating pulmonary hypertension
#713Process for the preparation of aclidinium bromide
#714Inhaler and methods of use thereof
#715Dry powder formulation of azole derivative for inhalation
#716Process for manufacturing dry powder blends
#717METHOD AND DEVICE FOR ADMINISTERING XINAFOATE SALT OF N4-(2,2-DIFLUORO-4H-BENZO[1,4]OXAZIN-3-ONE)-6-YL]-5-FLUORO-N2-[3-(METHYLAMINOCARBONYLMETHYLENEOXY)PHENYL]2,4-PYRIMIDINEDIAMINE
#718HAND-ACTUATED DRY POWDER INHALER AND ITS USE
#719Pulmonary Delivery for Levodopa
#720Method of making particles for use in a pharmaceutical composition
#721Device and method of delivering particles in the upper respiratory tract
#722Device and method of delivering particles in the upper respiratory tract
#723Powder compartment for high dosage drug delivery
#724Dosator apparatus for filling a capsule with dry powder
#725Technology for the Preparation of Microparticles
#726Combination therapy for COPD
#727UNIT FOR THE MICRONIZATION AND DOSAGE OF SOLID ACTIVE AGENTS
#728Salt of a pyrimido[6,1-A]isoquinolin-4-one compound
#729PROCESS FOR THE PREPARATION OF FORMULATIONS FOR INHALATION
#730Dry Powder Inhaler Comprising Fluticasone Propionate and Salmeterol Xinafoat
#731Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
#732Unit aerosol doses for anticoagulation
#733USE OF ACLIDINIUM
#7343,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
#735Use of Simple Amino Acids to Form Porous Particles
#736METHODS OF TREATING LUNG INFECTION WITH CASPOFUNGIN
#737Dry powder formulations for inhalation
#738NOVEL AEROSOL FORMULATIONS OF GRANISETRON AND USES THEREOF
#739Microparticles
#740NOVEL AEROSOL FORMULATIONS OF ONDANSETRON AND USES THEREOF
#741COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#742PROBIOTIC THERAPEUTIC APPLICATIONS
#743Pharmaceutical compositions
#744Composition comprising at least one dry powder obtained by spray drying to increase the stability of the formulation
#745Dry powder inhaler
#746STABLE POWDER FORMULATION CONTAINING AN ANTICHOLINGERIC AGENT
#747Pharmaceutical composition containing budesonide and formoterol
#748Quinuclidine derivatives and medicinal compositions containing the same
#749Matriptase inhibitors and uses thereof against orthomyxoviridae infections
#750Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture
#7511-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl) oxy) napththalen-1-yl) ureas as P38 MAP knase inhibitors
#752TIOTROPIUM DRY POWDERS
#753Methods for producing respirable dry powders
#754METHOD FOR TREATING HYPERGLYCEMIA WITH GLP-1
#755AN INHALABLE RAPAMYCIN FORMULATION FOR THE TREATMENT OF PULMONARY HYPERTENSION
#756IMPROVED STABILITY OF DRY POWDERS CONTAINING TIOTROPIUM AND AMINO ACID
#757FORMULATIONS CONTAINING TIOTROPIUM, AMINO ACID AND ACID AND METHODS THEREOF
#758INHALABLE AZTREONAM FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
#759Rapid Relief of Motor Fluctuations in Parkinson's Disease
#760Taurine compositions suitable for inhalation
#761PROCESS FOR IMPROVING CRYSTALLINITY
#762IDIOPATHIC PULMONARY FIBROSIS-DETECTION, MONITORING, PREDICTION METHODS
#763Diketopiperazine salts for drug delivery and related methods
#764Mast cell stabilizers treatment for systemic disorders
#765Particulate materials
#766Drug combination of PDE3/PDE4 inhibitor and muscarinic receptor antagonist
#767Method of making particles for use in a pharmaceutical composition
#768Formulation comprising glycopyrrolate, method and apparatus
#769Inhalable formulation
#770CRYSTALLINE Pl3 KINASE INHIBITORS
#771Improvements to Nasal Compositions and Method of Use Thereof
#772Dry powder formulation
#773Encapsulation of lipophilic ingredients in dispensible spray dried powders suitable for inhalation
#774Pharmaceutical anti-infective composition for inhalation
#775METHOD AND COMPOSITION FOR TREATING MIGRAINES
#776Method and formulation for inhalation
#777Dry Powder Inhaler
#778DRY POWDER INHALER FORMULATIONS COMPRISING SURFACE-MODIFIED PARTICLES WITH ANTI-ADHERENT ADDITIVES
#779Particles for use in a pharmaceutical composition
#780Antibiotic compositions for treating bacterial infections
#781Methods and compositions for treating pain
#782Methods for treating ocular contusion and blunt injury and traumatic injury of the optic nerve
#783COMBINATIONS OF FORMOTEROL AND BUDESONIDE FOR THE TREATMENT OF COPD
#784Preparation of micronized particles of an antimuscarinic compound by hydrodynamic cavitation
#785COMBINATIONS OF TIOTROPIUM BROMIDE, FORMOTEROL AND BUDESONIDE FOR THE TREATMENT OF COPD
#786Quinazolin-4 (3H)-one derivatives used as P13 kinase inhibitors
#787Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile
#788Methods of treating autoimmune, respiratory and inflammatory disorders by inhalation of roflumilast N-oxide
#789Use of ultrarapid acting insulin
#790Fluticasone furoate in the treatment of COPD
#791Diketopiperazine microparticles with defined specific surface areas
#792Inhibitor of p38 map kinase
#793Inhalable nicotine formulations, and methods of making and using thereof
#794Pharmaceutical compositions for inhalation
#795Process for preparing a medicament
#796DRY POWDER MIXING PROCESS
#7976-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
#798METHODS, COMPOSITIONS AND DEVICES FOR TREATMENT OF MOTOR AND DEPRESSION SYMPTOMS ASSOCIATED WITH PARKINSON'S DISEASE
#799Use of ultrarapid acting insulin
#800Use of Glutaryl Histamine for the Treatment of Respiratory Tract Diseases
#801A PROCESS FOR THE PREPARATION of DRY POWDER FORMULATIONS
#802NOVEL PROCESS FOR THE PREPARATION OF DRY POWDER FORMULATIONS
#803Monovalent metal cation dry powders for inhalation
#804Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#805Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic
#806Acetylcholinesterase inhibitors for treatment of dermatological conditions
#807COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#808NOVEL DOSAGE AND FORMULATION
#809Pharmaceutical Composition Comprising a Beta-2-Agonist and Anticholinergic Agent
#810INHALABLE EPINEPHRINE
#811Vaccination compositions, methods of making, and methods of use
#812Methods of treating or preventing fibrotic lung diseases
#813SUPERIOR CONTROL OF BLOOD GLUCOSE IN DIABETES TREATMENT
#814Dry-powder peptide medicament
#815DRY POWDER FORMULATION OF AZOLE DERIVATIVE FOR INHALATION
#816Chitin-glucan complex, its preparation, and uses
#817Nicotine formulations and methods of making and using the same
#818Inhalable nicotine formulations and methods of making and using the same
#819Thymic stromal lymphopoietin (TSLP)-binding molecules and methods of using the molecules
#820BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS
#821Improvements Relating To Inhalable Particles
#822COMPOSITIONS AND METHODS FOR THE TREATMENT OF SARCOIDOSIS
#823Methods of treating lung infection with caspofungin
#824COMBINATIONS COMPRISING ANTIMUSCARINIC AGENTS AND PDE4 INHIBITORS
#825PROSTACYCLIN COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF
#826Flavoured nicotine powder inhaler
#827Methods and Compositions for Delivering an Extract of Piper Methysticum
#828Pharmaceutical Composition
#829TREATMENT FOR RESPIRATORY DISEASE
#830Cationic dry powders
#831INHALABLE AZTREONAM LYSINATE FORMULATION FOR TREATMENT AND PREVENTION OF PULMONARY BACTERIAL INFECTIONS
#832An Inhalable Rapamycin Formulation for Treating Age-Related Conditions
#833Airflow adaptor for a breath-actuated dry powder inhaler
#8341-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as P38 MAP knase inhibitors
#835Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
#836Spray-dried solid-in-oil-in-water dispersions for inhalation of active pharmaceutical ingredients
#837Triptan powders for pulmonary delivery
#838Nanoparticle drug delivery
#839NASAL ADMINISTRATION
#840Mast cell stabilizers treatment for systemic disorders
#841miR-29 mimics and uses thereof
#842Respirable agglomerates of porous carrier particles and micronized drug
#843PROCESS FOR PREPARING CARRIER PARTICLES FOR DRY POWDERS FOR INHALATION
#844High capacity diketopiperazine microparticles and methods
#845Mast cell stabilizers treatment for systemic disorders
#846Assisted particle size reduction process
#847Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#848NEW USE OF ACLIDINIUM
#849Aerosol formulations of granisetron and uses thereof
#850Microparticle formulations for delivery to the lower and central respiratory tract and methods of manufacture
#851Particulate materials
#852Aerosol formulations of ondansetron and uses thereof
#853Prodrugs of dithiol mucolytic agents
#854Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#855PDE5 INHIBITOR POWDER FORMULATIONS AND METHODS RELATING THERETO
#856INHALABLE SUSTAINED THERAPEUTIC FORMULATIONS
#857ZOLMITRIPTAN POWDERS FOR PULMONARY DELIVERY
#858Inhalable medicaments
#859Dry powder inhaler
#860NOVEL DOSAGE FORM AND FORMULATION OF ABEDITEROL
#861Quinuclidine derivatives and medicinal compositions containing the same
#862Dry powder drug delivery system
#863COMBINATIONS OF MEDICAMENTS FOR THE TREATMENT OF RESPIRATORY DISEASES
#864Use of Simple Amino Acids to Form Porous Particles
#865INHALER FOR THE ADMINISTRATION OF AN ANTICHOLINERGIC
#866Particle size reduction of an antimuscarinic compound
#867Therapeutic for treating inflammatory lung disorders
#868Cromolyn derivatives and related methods of imaging and treatment
#869Formulations useful in the treatment of proliferative diseases affecting the respiratory tract
#870Use of MKS inhibitor peptide-containing compositions for treating non-small cell lung cancer with same
#871Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
#872STABLE POWDER FORMULATION CONTAINING AN ANTICHOLINGERIC AGENT
#873Aclidinium for use in improving the quality of sleep in respiratory patients
#874Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalation
#875Prostacyclin compounds, compositions and methods of use thereof
#876Diketopiperazine salts for drug delivery and related methods
#877DRY POWDER INHALER
#878Method of making particles for use in a pharmaceutical composition
#879Method Of Making Particles For Use In A Pharmaceutical Composition
#880Spray-dry formulations
#881Process for preparing a medicament
#882Rapamycin for the treatment of lymphangioleiomyomatosis
#883METHOD AND APPARATUS FOR MAKING COMPOSITIONS FOR PULMONARY ADMINISTRATION
#884Propofol formulations with non-reactive container closures
#885Dry powder inhaler and system for drug delivery
#886Methods and compositions for treating mucusal tissue disorders
#887DRY POWDER INHALERS COMPRISING A CARRIER OTHER THAN LACTOSE AND A TERNARY COMPONENT
#888METHODS FOR TREATING AND/OR PREVENTING EMESIS AND/OR NAUSEA INCLUDING ACUTE AND/OR DELAYED NAUSEA AND/OR ACUTE EMESIS AND/OR DELAYED EMESIS
#889Dry powder inhaler
#890Formulation of MK2 inhibitor peptides
#891Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activities
#892Manufacture of Pharmaceutical Compositions
#893Inhalable Pharmaceutical Compositions and the Inhaler Devices Containing Them
#894Inhaler
#895PULMONARY PHARMACEUTICAL FORMULATIONS
#896Use of glycopyrrolate for treating tachycardia
#897INHALATION COMPOSITION FILLING METHOD
#898METHOD FOR PREVENTING INFLUENZA VIRUS INFECTION BY ADMINISTERING A DRY POWDER PHARMACEUTICAL COMPOSITION
#899Rapamycin powders for pulmonary delivery
#900Tiotropium dry powders